US 10046036
Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria
granted A61KA61K31/198A61K31/205
Quick answer
US patent 10046036 (Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/198, A61K31/205, A61K31/385, A61K38/51